SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 31, 2003 Progenics Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter) Delaware 000-23143 13-3379479 (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) 777 Old Saw Mill River Road, Tarrytown, New York 10591 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (914) 789-2800 (Former name or former address, if changed since last report.) Item 5. Other Events and Required FD Disclosure On October 31, 2003, Progenics Pharmaceuticals, Inc. (the "Company"), issued a press release in which the Company announced, among other things, its results of operations for the quarter and nine months ended September 30, 2003. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated in this Item 5 by reference. Item 7. Financial Statements, Pro Forma Financial Information and Exhibits. (c) Exhibits EXHIBIT NUMBER DESCRIPTION Exhibit 99.1 Press Release dated October 31, 2003 of the Company announcing its results of operations for the quarter and nine months ended September 30, 2003 (filed herewith). Item 12. Results of Operations and Financial Condition. The Company furnishes its press release dated October 31, 2003, in which the Company announces, among other things, its results of operations for the quarter and nine months ended September 30, 2003. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PROGENICS PHARMACEUTICALS, INC. By: /s/ PHILIP K. YACHMETZ -------------------------- Philip K. Yachmetz Vice President, General Counsel and Secretary Date: October 31, 2003